These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1788324)

  • 1. Application of nonlinear regression to the estimation of in vitro antagonist dissociation constants and relative potency problems.
    Kramer TH
    Proc West Pharmacol Soc; 1991; 34():425-7. PubMed ID: 1788324
    [No Abstract]   [Full Text] [Related]  

  • 2. The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processes.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1981 Oct; 219(1):112-20. PubMed ID: 7288599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. II. Competitive antagonists.
    Waud DR; Parker RB
    J Pharmacol Exp Ther; 1971 Apr; 177(1):13-24. PubMed ID: 5566759
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of drug-receptor affinity measures in the differentiation of receptors.
    Tallarida RJ
    Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug combinations; feasibilities and limitations].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1973 Mar; 117(11):434-51. PubMed ID: 4569839
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council.
    Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic quantitation.
    Patil PN
    Indian J Exp Biol; 1996 Jul; 34(7):615-33. PubMed ID: 8979496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociation.
    Vauquelin G; Szczuka A
    Neurochem Int; 2007 Oct; 51(5):254-60. PubMed ID: 17606314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow antagonist dissociation and long-lasting in vivo receptor protection.
    Vauquelin G; Van Liefde I
    Trends Pharmacol Sci; 2006 Jul; 27(7):356-9. PubMed ID: 16766051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General estimation of relative potency using prior information.
    Kim PT; Cho GW; Carter EM; Hubert JJ
    J Biopharm Stat; 1992; 2(2):171-80. PubMed ID: 1300211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
    Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
    J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic drug interactions.
    Rawlins MD
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1574-7. PubMed ID: 611882
    [No Abstract]   [Full Text] [Related]  

  • 13. An estimate of the muscarinic ganglion blocking potency of atropine.
    Sethi OP; Gulati OD
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):179-82. PubMed ID: 4401548
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology for the dental practitioner. 1. General principles of drug action.
    Walton JG; Thompson JW
    Br Dent J; 1969 Jul; 127(1):29-34. PubMed ID: 5256256
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional methods for quantifying agonists and antagonists.
    Dougall LG
    J Recept Signal Transduct Res; 2001; 21(2-3):117-37. PubMed ID: 11757680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new kind of drug antagonism: evidence that agonists cause a molecular change in acetylcholine receptors.
    Rang HP; Ritter JM
    Mol Pharmacol; 1969 Jul; 5(4):394-411. PubMed ID: 5805474
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantum pharmacology: charge transfer in the complexation of antagonists with the pharmacologic receptors].
    Korolkovas A; Tamashiro K
    Rev Paul Med; 1974 Jun; 83(6):295-9. PubMed ID: 4438909
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug interactions.
    Azarnoff DL; Hurwitz A
    Pharmacol Physicians; 1970 Feb; 4(2):1-7. PubMed ID: 5450332
    [No Abstract]   [Full Text] [Related]  

  • 19. [A molecular basis for the action of drugs. 3. Substances with multiple action].
    van den Brink FG
    Arzneimittelforschung; 1966 Nov; 16(11):1403-12. PubMed ID: 6015002
    [No Abstract]   [Full Text] [Related]  

  • 20. [A molecular basis for the action of drugs. 2. Different types of antagonists].
    Simonis AM; Ariëns EJ
    Arzneimittelforschung; 1966 Nov; 16(11):1393-403. PubMed ID: 4234662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.